Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000950170-25-004198

Chief Executive Officer sold 21,172 shares at $8.22 ($173,996)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Tak Paul Peter Chief Executive Officer 2025-01-08 Sale −21,172 $8.22 $173,996 273,616 D: show line 1 in the form
Open-market sales · 21,172 sh · avg $8.22 · $173,996
Loading xslF345X05/ownership.xml…